Clinical perspectives on reperfusion injury in acute myocardial infarction

American Heart Journal

Volumn 167, Issue 5, 2014, Pages 637-645

  Bainey, Kevin R ^a   Armstrong, Paul W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CALCIUM CHANNEL BLOCKING AGENT; COMPLEMENT; FATTY ACID; FIBRINOGEN RECEPTOR ANTAGONIST; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; INTERLEUKIN DERIVATIVE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; REACTIVE OXYGEN METABOLITE;

ACUTE HEART INFARCTION; CALCIUM CELL LEVEL; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MAGNETIC RESONANCE; CELL FUNCTION; COOLING; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OCCLUSION; GATED SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE INJURY; HEART MUSCLE METABOLISM; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; INVASIVE ISCHEMIC CONDITIONING; ISCHEMIC CONDITIONING; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MICROVASCULATURE; MITOCHONDRIA TARGETED THERAPY; MOLECULARLY TARGETED THERAPY; MULTICENTER STUDY (TOPIC); NO REFLOW PHENOMENON; NONHUMAN; OXYGEN SATURATION; PERCUTANEOUS CORONARY INTERVENTION; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION INJURY; REVIEW; ST SEGMENT; SYSTEMATIC REVIEW;

ANIMALS; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIAL REVASCULARIZATION; MYOCYTES, CARDIAC;

EID: 84899535288     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.01.015     Document Type: Review

References (53)

1. D.M. Yellon, and D.J. Hausenloy Myocardial reperfusion injury N Engl J Med 357 2007 1121 1135
2. R.B. Jennings, H.M. Sommers, and G.A. Smyth et al. Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog Arch Pathol 70 1960 68 78
3. B.H. Bulkely, and G.M. Hutchins Myocardial consequences of coronary artery bypass graft surgery. Cooling as an adjunctive therapy to percutaneous Circulation 56 1977 906 913
4. E. Braunwald, and R.A. Kloner Myocardial reperfusion: a double-edged sword? J Clin Invest 76 1985 1713 1719
5. R.A. Kloner, C.E. Ganote, and R.B. Jennings The "no-reflow" phenomenon after temporary coronary occlusion in the dog J Clin Invest 54 1974 1496 1508
6. R.H. Mehta, K.J. Harjai, and D. Cox et al. Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention J Am Coll Cardiol 42 2003 1739 1746
7. C.M. Gibson, S.A. Murphy, and S.J. Marble et al. Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study Group Am J Cardiol 87 2001 450 453
8. C.M. Gibson, C.P. Cannon, and S.A. Murphy et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs Circulation 101 2000 125 130
9. C.E. Buller, Y. Fu, and K.W. Mahaffey et al. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial Circulation 118 2008 1335 1346
10. K.R. Bainey, Y. Fu, and G.S. Wagner et al. Spontaneous reperfusion in ST-elevation myocardial infarction: comparison of angiographic and electrocardiographic assessments Am Heart J 156 2008 248 255
11. S.H. Rezkalla, and R.A. Kloner No-reflow phenomenon Circulation 105 5 2002 656 662
12. Y. Xu, Y. Huo, and M.C. Toufektsian et al. Activated platelets contribute importantly to myocardial reperfusion injury Am J Physiol Heart Circ Physiol 290 2006 H692 H699
13. R.B. Jennings, and K.A. Reimer Factors involved in salvaging ischemic myocardium: effect of reperfusion of arterial blood Circulation 6 1983 I25 I36
14. A. Saraste, K. Pulkki, and M. Kallajoki et al. Apoptosis in human acute myocardial infarction Circulation 95 1997 320 323
15. G. De Luca, H. Suryapranata, and G.W. Stone et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials JAMA 293 2005 1759 1765
16. J.T. Flaherty, B. Pitt, and J.W. Gruber et al. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction Circulation 89 1994 1982 1991
17. W. Guan, T. Osanai, and T. Kamada et al. Effect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarction J Cardiovasc Pharmacol 41 2003 699 705
18. K. Tsujita, H. Shimomura, and K. Kaikita et al. Long-term efficacy of edaravone in patients with acute myocardial infarction Circ J 70 2006 832 837
19. Q. Su, L. Li, and Y. Liu Short-term effect of verapamil on coronary no-reflow associated with percutaneous coronary intervention in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trials Clin Cardiol 36 2013 E11 E16
20. F.W. Bar, D. Tzivoni, and M.T. Dirksen et al. Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI study Eur Heart J 27 2006 2516 2523
21. D.P. Faxon, R.J. Gibbons, and N.A. Chronos et al. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study J Am Coll Cardiol 40 2002 1199 1204
22. P. Mertens, A. Maes, and J. Nuyts et al. Recombinant P-selectin glycoprotein ligand-immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial Am Heart J 152 2006 125.e1 125.e8
23. C.B. Granger, K.W. Mahaffey, and W.D. Weaver et al. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial Circulation 108 2003 1184 1190
24. P.W. Armstrong, C.B. Granger, and P.X. Adams et al. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial JAMA 297 2007 43 51
25. C. Martel, C.B. Granger, and M. Ghitescu et al. Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial Am Heart J 164 2012 43 51
26. A.M. Ross, R.J. Gibbons, and G.W. Stone et al. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II) J Am Coll Cardiol 45 2005 1775 1780
27. S.R. Mehta, S. Yusuf, and R. Diaz et al. Effect of glucose-insulin- potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial JAMA 293 2005 437 446
28. K.R. Bainey, Y. Fu, and C.B. Granger et al. Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients? Heart 95 2009 1331 1336
29. K. Malmberg, L. Ryden, and H. Wedel et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity Eur Heart J 26 2005 650 661
30. C.E. Murry, R.B. Jennings, and K.A. Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136
31. S.P. Hoole, P.M. Heck, and L. Sharples et al. Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) study: a prospective, randomized control trial Circulation 119 2009 820 827
32. W.R. Davies, A.J. Brown, and W. Watson et al. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP Stent trial long-term follow-up Circ Cardiovasc Interv 6 2013 246 251
33. H.E. Botker, R. Kharbanda, and M.R. Schmidt et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial Lancet 375 2010 727 734
34. R.A. Kloner, T. Shook, and K. Przyklenk et al. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation 91 1995 37 45
35. P. Staat, G. Rioufol, and C. Piot et al. Postconditioning the human heart Circulation 112 2005 2143 2148
36. W.K. Laskey Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study Catheter Cardiovasc Interv 65 2005 361 367
37. H. Thibault, C. Piot, and P. Staat et al. Long-term benefit of postconditioning Circulation 117 2008 1037 1044
38. G. Tarantini, E. Favaretto, and M.P. Marra et al. Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial Int J Cardiol 162 2012 33 38
39. X. Freixa, N. Bellera, and J.T. Ortiz-Perez et al. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention Eur Heart J 33 2012 103 112
40. W.W. O'Neill, J.L. Martin, and S.R. Dixon et al. Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention J Am Coll Cardiol 50 2007 397 405
41. G.W. Stone, J.L. Martin, and M.J. de Boer et al. Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction Circ Cardiovasc Interv 2 2009 366 375
42. C. Piot, P. Croisille, and P. Staat et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction N Engl J Med 359 2008 473 481
43. Ovize M. Does Cyclosporine ImpRove Clinical oUtcome in ST Elevation Myocardial Infarction Patients. ClinicalTrials.gov identifier: NCT01502774.
44. Latini R. CYCLosporinE A in Reperfused Acute Myocardial Infarction Prospective, Controlled, Randomized, Multicentre Trial to Examine Whether a Single i.v. Bolus of Cyclosporine A Before PCI Can Reduce Myocardial Reperfusion Injury in Patients With STEMI. ClinicalTrials.gov identifier: NCT01650662.
45. A.K. Chakrabarti, K. Feeney, and C. Abueg et al. Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction Am Heart J 165 2013 509 514
46. J. Lonborg, N. Vejlstrup, and H. Kelbaek et al. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction Eur Heart J 33 2012 1491 1499
47. F.J. Bernink, L. Timmers, and M. Diamant et al. Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction: the EXAMI study Int J Cardiol 167 2013 289 290
48. S.R. Dixon, R.J. Whitbourn, and M.W. Dae et al. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction J Am Coll Cardiol 40 2002 1928 1934
49. W.W. O'Neill A randomized trial of mild hypothermia during PCI treatment of ST elevation MI Presented at Transcatheter Cardiovascular Therapeutics 2003
50. Carrozza J.P. COOL MI II: Cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction. ClinicalTrials.gov: NCT00248196.
51. Erlinge D. Efficacy of Endovascular Catheter Cooling Combined With Cold Saline for the Treatment of Acute Myocardial Infarction (CHILL-MI). ClinicalTrials.gov Identifier: NCT01379261.
52. T. Taher, Y. Fu, and G.S. Wagner et al. Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy J Am Coll Cardiol 44 2004 38 43
53. M. Francone, C. Bucciarelli-Ducci, and I. Carbone et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance J Am Coll Cardiol 54 2009 2145 2153